The estimated Net Worth of W Gerald Austen is at least $32.9 Million dollars as of 24 February 2015. W Austen owns over 6,000 units of Abiomed stock worth over $31,754,588 and over the last 22 years W sold ABMD stock worth over $1,098,120.
W has made over 11 trades of the Abiomed stock since 2006, according to the Form 4 filled with the SEC. Most recently W sold 6,000 units of ABMD stock worth $363,720 on 24 February 2015.
The largest trade W's ever made was exercising 25,000 units of Abiomed stock on 20 July 2006 worth over $175,000. On average, W trades about 5,292 units every 131 days since 2003. As of 24 February 2015 W still owns at least 83,341 units of Abiomed stock.
You can see the complete history of W Austen stock trades at the bottom of the page.
W's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose, and David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: